# Dose-Proportionality and Intra-Individual Variability of Intracellular TFV-DP and FTC-TP in Healthy Volunteers

> **NCT01276600** · PHASE1 · COMPLETED · sponsor: **HIV Prevention Trials Network** · enrollment: 32 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Emtricitabine/tenofovir

## Key facts

- **NCT ID:** NCT01276600
- **Lead sponsor:** HIV Prevention Trials Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01276600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01276600, "Dose-Proportionality and Intra-Individual Variability of Intracellular TFV-DP and FTC-TP in Healthy Volunteers". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT01276600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*